One of the more typical applications involves increasing the levels of CD10 within tissues to treat diseases caused by Aβ accumulation, such as AD (Nalivaeva and Turner, 2019) (refer to Section 2.3) and retinal diseases. Here, MME is linked to Abnormal retinal morphology.